✦ LIBER ✦

Circulating Tumor Cells and Detection of the Melanoma-Associated Antigen HMW-MAA in the Serum of Melanoma Patients

✍ Scribed by Ulmer, Anja; Fierlbeck, Gerhard

Book ID: 110049235
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 43 KB
Volume: 126
Category: Article
ISSN: 0022-202X
DOI: 10.1038/sj.jid.5700158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to: Circulating Tumor Cells and

Response to: Circulating Tumor Cells and Detection of Melanoma-Associated Antigen HMW-MAA in the Serum of Melanoma Patients

✍ Reynolds, Sandra R; Ferrone, Soldano; Bystryn, Jean-Claude 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB

Regulation of high molecular weight-mela

Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells

✍ Luo, W; Wang, X; Kageshita, T; Wakasugi, S; Karpf, A R; Ferrone, S 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 614 KB

Characterization of circulating T cells

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

✍ Davis, Mark M.; Lee, Peter P.; Yee, Cassian; Savage, Peter A.; Fong, Lawrence; B 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 220 KB

Suppression of human melanoma tumor grow

Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody

✍ Christine Hafner; Heimo Breiteneder; Soldano Ferrone; Christiane Thallinger; Ste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB

## Abstract The lack of efficacy of available therapies for the treatment of malignant melanoma has emphasized the need to develop novel therapeutic strategies to prevent melanoma growth. We have tested whether the anti‐HMW‐MAA mAb 225.28S is able to inhibit human melanoma tumor growth in SCID mice

Cytoplasmic melanoma-associated antigen

Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: A potential marker of response to immunotherapy?

✍ Sandra R. Reynolds; Irene J. Vergilis; Michael Szarek; Soldano Ferrone; Jean-Cla 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB

## Abstract Simple, noninvasive methods are needed to follow effectiveness of new treatments in patients with melanoma. In our study, we examined cytoplasmic melanoma‐associated antigen (CYT‐MAA) serum level in melanoma patients during immunotherapy. Sera of 117 patients were assayed for CYT‐MAA by

Detection of tumor-associated antigen in

Detection of tumor-associated antigen in human melanoma cell line supernatants

✍ Elizabeth A. Grimm; Hulbert K. B. Silver; Jack A. Roth; Darwin O. Chee; Rishab K 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 477 KB

## Abstract Spent tissue culture medium (CDM‐S) removed from a single cell line of human malignant melanoma grown in serum‐free CDM, contained tumor‐associated antigenic activity. Antibodies to CDM‐S measured by complement fixation were detected in 44% (31/70) melanoma, 55% (15/27) sarcoma, 63% (24